🔎 Trials Near Me

Dachaigh › Aillse Sgamhain Neo-chealla-beag › California › San Diego

Sgrùdaidhean clionaigeach Aillse Sgamhain Neo-chealla-beag ann an San Diego, CA

Tha 48 sgrùdaidhean airson Aillse Sgamhain Neo-chealla-beag a’ lorg phàirtichean aig làraichean ann agus timcheall air San Diego (taobh a-staigh mu 30 mìle). Fosglaidh sgrùdadh gus faicinn cò as urrainn pàirt a ghabhail agus mar a chuireas tu fios air an sgioba.

Teacsa sgrùdaidh oifigeil (Beurla)

A’ fastadh airson sgrùdadh an seo? Seall e aig mullach na duilleige seo — $99 airson 30 latha →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

A’ fastadhÌre 3
  • Kaiser Permanente-San Diego Zion, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04267848

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

A’ fastadhÌre 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT06465069

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

A’ fastadhÌre 1/2
  • University of San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 2 Dàmh 2026 · NCT04585750

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

A’ fastadhÌre 3
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06498635

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

A’ fastadhÌre 1
  • University of California San Diego Moores Cancer Center, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Dàmh 2026 · NCT06625775

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

A’ fastadhÌre 1
  • ALX Center 9, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07085091

A Study of PHN-012 in Patients With Advanced Solid Tumors

A’ fastadhÌre 1
  • PHN-012-001 Site, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT07127874

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

A’ fastadhÌre 2
  • University of California at San Diego, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT05498428

A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)

A’ fastadhÌre 3
  • UC San Diego McGrath Outpatient Pavilion - Hillcrest, San Diego
  • UC San Diego Medical Center - Hillcrest, San Diego
  • UCSD Medical Center - Rancho Bernardo, San Diego
  • agus 3 a bharrachd
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 28 Sult 2026 · NCT07144280

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

A’ fastadhSgrùdadh amharc
  • University of California San Diego, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT04981119

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

A’ fastadhÌre 2
  • Moores Cancer Center at UC San Diego Health, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06667908

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

A’ fastadhÌre 2
  • University of California San Diego Health, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06667076

Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers

A’ fastadhÌre 1/2
  • Scripps Clinic Torrey Pines (Scripps Cancer Center), La Jolla · 11 mìle air falbh
  • Scripps Green Hospital, La Jolla · 11 mìle air falbh
  • Scripps Shiley Pavilion, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT07227298

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

A’ fastadhÌre 3
  • Kaiser Permanente San Diego Mission Road, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06890598

Pan-tumor MRD Study

A’ fastadhSgrùdadh amharc
  • Medical Oncology Associates of San Diego (MOASD), San Diego
  • Medical Oncology Associates of San Diego, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT06605404

Intratumoral N17350 in Advanced Solid Tumors

A’ fastadhÌre 1/2
  • Scripps Clinic Torrey Pines - La Jolla, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT07339176

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

A’ fastadhÌre 2/3
  • University Of California - San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 22 Sult 2026 · NCT06712316

Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patients With High PD-L1

A’ fastadhÌre 3
  • Clinical Study Site, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Sult 2026 · NCT06767514

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

A’ fastadhSgrùdadh amharc
  • University of California, San Diego, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT05059444

A Phase 1/1b Study of IAM1363 in HER2 Cancers

A’ fastadhÌre 1
  • UCSD Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2026 · NCT06253871

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

A’ fastadhÌre 1
  • University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT06400472

Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations

A’ fastadhÌre 3
  • Research Site, San Diego
  • Research Site, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07291037

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

A’ fastadhÌre 1
  • University of California - San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06343402

Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

A’ fastadhÌre 3
  • Sharp Memorial Hospital ( Site 9544), San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06422143

FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors

A’ fastadhÌre 1
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT07216105

A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

A’ fastadhÌre 1
  • University of California San Diego, Moores Cancer Center, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Sult 2026 · NCT04913285

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

A’ fastadhÌre 3
  • Research Site, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT06350097

Study to Assess the Efficacy and Safety of Rina-S in Participants With Non-small Cell Lung Cancer

A’ fastadhÌre 2
  • Kaiser Permanente San Diego Mission Road, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Lùna 2026 · NCT07288177

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

A’ fastadhÌre 3
  • UC San Diego Medical Center - Hillcrest, San Diego
  • California Protons Cancer Therapy Center, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Lùna 2026 · NCT06500481

A Study of BH-30643 in Subjects With Locally Advanced or Metastatic NSCLC Harboring EGFR and/or HER2 Mutations

A’ fastadhÌre 1/2
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Lùna 2026 · NCT06706076

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

A’ fastadhÌre 1/2
  • University of California, San Diego; Moores Cancer Center, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT05579366

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

A’ fastadhÌre 1/2
  • University of California, San Diego Moores Cancer Center, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Ògmh 2026 · NCT06162221

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

A’ fastadhÌre 1/2
  • UCSD Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 12 Ògmh 2026 · NCT06051695

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Ògmh 2026 · NCT05642572

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

A’ fastadhÌre 1
  • University of California San Diego Moores Cancer Center, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Ògmh 2026 · NCT06917079

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

A’ fastadhÌre 3
  • Research Site, San Diego
  • Research Site, La Jolla · 11 mìle air falbh
Aoisean 18 gu 130 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT06417814

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 6 Cèit 2026 · NCT06116682

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2/3
  • Kaiser Permanente-San Diego Zion, San Diego
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06616584

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

A’ fastadhÌre 2
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
18 Minutes · Gach gnè · Air ùrachadh 5 Cèit 2026 · NCT06031688

A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC

A’ fastadhÌre 2
  • University of California San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Gibl 2026 · NCT06010329

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

A’ fastadhÌre 1/2
  • University of California San Diego (UC San Diego) Health - Jacobs Medical Center - Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 18 Màrt 2026 · NCT06244771

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

A’ fastadhÌre 1/2
  • Research Site, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 2 Màrt 2026 · NCT06956690

EZH2 Inhibitor, Tulmimetostat, and PD-1 Blockade for Treatment of Advanced Non-small Cell Lung Cancer

A’ fastadhÌre 1/2
  • VA San Diego Healthcare System, San Diego, CA, San Diego
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 27 Faoi 2026 · NCT05467748

Retifanlimab and Ruxolitinib In Solid Malignancies

A’ fastadhÌre 1/2
  • University of California, San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 13 Faoi 2026 · NCT07219576

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

A’ fastadhSgrùdadh amharc
  • Massive Bio SYNERGY-AI site, La Jolla · 11 mìle air falbh
Gach aois · Gach gnè · Air ùrachadh 28 Dàmh 2025 · NCT03452774

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

A’ fastadhÌre 1/2
  • UCSD Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 9 Sult 2025 · NCT06682793

Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies

A’ fastadhÌre 1
  • UC San Diego Moores Cancer Center, La Jolla · 11 mìle air falbh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Gearr 2024 · NCT04282044

Sgrùdaidhean Aillse Sgamhain Neo-chealla-beag ann am bailtean eile

Sgrùdaidhean eile ann an San Diego

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.